Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs

By Ieiri Ichiro   Higuchi Shun   Sugiyama Yuichi  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 7, 2009-07 ,pp. : 703-729

Informa Healthcare

Access to resources Recommend Favorite

Culture Duration-, Donor-, and Medium-Dependent Changes in OATP1B3- Mediated Telmisartan Uptake in Human Hepatocytes

By  

Drug Metabolism Letters, Vol. 7, Iss. 2, 2014-05 ,pp. : 117-125

Bentham Science Publishers

Access to resources Recommend Favorite

In Vitro and In Silico Strategies to Identify OATP1B1 Inhibitors and Predict Clinical Drug–Drug Interactions

By Karlgren Maria   Ahlin Gustav   Bergström Christel   Svensson Richard   Palm Johan   Artursson Per  

Pharmaceutical Research, Vol. 29, Iss. 2, 2012-02 ,pp. : 411-426

Springer Publishing Company

Access to resources Recommend Favorite

Rapid identification of three functionally relevant polymorphisms in the OATP1B1 transporter gene using Pyrosequencing™

By Rohrbacher Maren   Kirchhof Anja   Skarke Carsten   Geisslinger Gerd   Lötsch Jörn  

Pharmacogenomics, Vol. 7, Iss. 2, 2006-03 ,pp. : 167-176

Future Medicine

Access to resources Recommend Favorite

Role of OATP transporters in the disposition of drugs

By Niemi Mikko  

Pharmacogenomics, Vol. 8, Iss. 7, 2007-07 ,pp. : 787-802

Future Medicine

Access to resources Recommend Favorite